Cellbricks
Cellbricks is a Berlin and Boston-based biotech company pioneering the future of regenerative medicine through biofabricated human tissue therapeutics.
About
Cellbricks is a preclinical biotech company with locations in Berlin and Boston specializing in regenerative medicine and longevity. The company leverages proprietary light-based biofabrication technology, advanced biomaterials, and human cells to develop implantable tissue grafts that can restore lost or damaged tissue and organ function. Cellbricks aims to address major unmet medical needs such as complex wounds, soft tissue defects, and chronic organ disease, providing scalable, immune-compatible, and functional tissue therapeutics. Their mission is to transform healthcare by restoring tissue function reliably and at scale.
Products & Services
- Biofabricated human tissue therapeutics
- Soft tissue therapeutics for wound healing (e.g., for deep complex wounds)
- Liver tissue therapeutics for restoring liver function in chronic liver disease
- 3D-bioprinted tissue implants
- Proprietary light-based biofabrication system
- AI-driven tissue engineering software
Use Cases & Case Studies
- Soft tissue repair and wound healing (complex wounds, trauma care, reconstructive surgery)
- Biological alternatives to synthetic implants (e.g., breast reconstruction)
- Restoration of liver function in chronic liver disease
Partnerships & Collaborations
- Charité University Hospital
- Advanced Regenerative Manufacturing Institute (ARMI)
- Creative Destruction Lab
- Bundesministerium für Wirtschaft und Energie (Federal Ministry for Economic Affairs and Energy, Germany)
- The Engine (MIT-affiliated incubator)
- Act Venture Partners
- VU
- B-Value
- ESF (European Social Fund)
Awards & Recognition
- Listed among the most promising biofabrication companies worldwide by PitchBook
- Featured as 'Startup of the Week' by StartingUp